Hedge fund could derail McKesson's $8.3bn Celesio buyout
This article was originally published in Scrip
Executive Summary
The German pharmaceutical distributor Celesio reported on 26 November that a hedge fund run by Elliott Asset Management has increased its stock ownership, giving it control of 25.16% of the company's shareholder voting rights. That may be enough to derail McKesson's $8.3bn acquisition of Celesio.